MitraClip® procedure as bridge to left ventricular assist device: Enable extracorporeal membrane oxygenation weaning and reduce perioperative risk

Perfusion. 2023 Apr;38(3):651-653. doi: 10.1177/02676591211065251. Epub 2022 Jan 3.

Abstract

Secondary mitral valve regurgitation is a frequent consequence of left ventricular dysfunction in patients with severe heart failure. The management of this disease can be challenging since it often culminates in refractory pulmonary edema and multi-organ failure. We present the case of a 50-year-old male who was admitted in cardiogenic shock following myocardial infarction. After successful revascularization, percutaneous mitral valve repair using the MitraClip® device enabled weaning from extracorporeal membrane oxygenation followed by the implantation of a left ventricular assist device as bridge to transplant.

Keywords: Impella® microaxial blood pump; MitraClip®, extracorporeal membrane oxygenation; cardiac shock; left ventricular assist device; mitral regurgitation, end-stage heart failure.

Publication types

  • Case Reports

MeSH terms

  • Extracorporeal Membrane Oxygenation* / methods
  • Heart-Assist Devices*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction* / complications
  • Shock, Cardiogenic / complications
  • Shock, Cardiogenic / surgery
  • Treatment Outcome